Lisinopril and Hydrochlorothiazide NDC 71205-022

NDC codes

FDA NDC Directory

Product NDC (as listed)71205-022Labeler and product segments. Claims need a package NDC.

Product NDC at billing width71205-0022Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
71205-022-00	71205002200	100 TABLET in 1 BOTTLE (71205-022-00)Marketed from May 1, 2018
71205-022-30	71205002230	30 TABLET in 1 BOTTLE (71205-022-30)Marketed from May 1, 2018
71205-022-60	71205002260	60 TABLET in 1 BOTTLE (71205-022-60)Marketed from May 1, 2018
71205-022-90	71205002290	90 TABLET in 1 BOTTLE (71205-022-90)Marketed from May 1, 2018

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Lisinopril and Hydrochlorothiazide
Generic name (nonproprietary): lisinopril and hydrochlorothiazide
Active ingredients: Hydrochlorothiazide — 12.5 mg/1Lisinopril — 20 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Proficient Rx LP
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 077912
Marketing start: Apr 10, 2006
Listing expires: Dec 31, 2026
Other FDA classes: Angiotensin-converting Enzyme Inhibitors (Mechanism)Increased Diuresis (Physiologic effect)Thiazides (Chemical structure)
Identifiers: Product ID 71205-022_c4893485-e865-4537-8bd8-77de435525f8SPL ID c4893485-e865-4537-8bd8-77de435525f8SPL set ID 2bcd9e20-2839-4cc0-9d1d-74b2cf17a96eRxCUI 197886UNII 0J48LPH2TH, E7199S1YWRUPC 0371205022303
Pharmacologic class: Angiotensin Converting Enzyme Inhibitor; Thiazide Diuretic

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N471205002200 followed by a unit qualifier and the quantity

Package 71205-0022-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective May 1, 2022. This label includes a boxed warning.

Indications (excerpt from the label)

INDICATIONS AND USAGE Lisinopril and hydrochlorothiazide tablets USP are indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure lowers the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions. These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including lisinopril and hydrochlorothiazide. Control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. Many patients will …

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)